Vedolizumab induction therapy for inflammatory bowel disease in clinical practice - a nationwide consecutive German cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vedolizumab induction therapy for inflammatory bowel disease in clinical practice - a nationwide consecutive German cohort study

Published:2016-04-01 Issue:10 Volume:43 Page:1090-1102
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Baumgart D. C.¹,Bokemeyer B.²,Drabik A.³,Stallmach A.⁴,Schreiber S.⁵,

Affiliation:

1. Department of Gastroenterology and Hepatology; Charité Medical School; Humboldt-University of Berlin; Berlin Germany

2. Gastroenterology Practice; Minden Germany

3. Biostatistics Consulting; Münster Germany

4. Department of Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases); University Hospital Jena; Jena Germany

5. Department Internal Medicine I; University Hospital Schleswig-Holstein Campus; Kiel University of Schleswig-Holstein; Kiel Germany

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13594/fullpdf

Reference43 articles.

1. Crohn's disease;Baumgart;Lancet,2012

2. Ulcerative colitis;Ordás;Lancet,2012

3. The Expenditures for Academic Inpatient Care of Inflammatory Bowel Disease Patients Are Almost Double Compared with Average Academic Gastroenterology and Hepatology Cases and Not Fully Recovered by Diagnosis-Related Group (DRG) Proceeds;Baumgart;PLoS One.,2016

4. Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques;Selby;Gut,1984

5. Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis;Thomas;Inflammopharmacology,2012

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A metabolomics-driven model for early remission prediction following vedolizumab treatment in patients with moderate-to-severe active ulcerative colitis;International Immunopharmacology;2024-02

2. Beyond the Gut: A Systematic Review and Meta-analysis of Advanced Therapies for Inflammatory Bowel Disease-associated Extraintestinal Manifestations;Journal of Crohn's and Colitis;2024-01-08

3. Treat to target in Crohn’s disease: A practical guide for clinicians;World Journal of Gastroenterology;2024-01-07

4. Selective granulocyte–monocyte apheresis during induction with vedolizumab in moderate–severe ulcerative colitis: Experience in a tertiary hospital;Gastroenterología y Hepatología;2024-01

5. Efficacy and Safety of Vedolizumab in Patients with Inflammatory Bowel Disease in Association with Vedolizumab Drug Levels;Journal of Clinical Medicine;2023-12-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3